Results 161 to 170 of about 829,080 (295)
In over 50% of non‐metastatic breast cancer patients, circulating tumor cells (CTCs) along the whole epithelial‐mesenchymal transition spectrum are detected. Total CTC number and individual phenotypes relate to aggressive disease characteristics, including lymph node involvement and higher tumor proliferation. At the single‐cell level, mesenchymal CTCs
Justyna Topa+14 more
wiley +1 more source
A laboratory experiment on using different financial-incentivization schemes in software-engineering experimentation. [PDF]
Bershadskyy D+6 more
europepmc +1 more source
The GOODSTEP project: general object-oriented database for software engineering processes [PDF]
openalex +1 more source
The IFNγ‐CIITA‐MHC II axis modulates melanoma cell susceptibility to NK‐cell‐mediated cytotoxicity
Natural killer (NK) cells play a central role in anti‐melanoma immunity. However, melanoma cells adapt during co‐culture by upregulating CIITA and MHC II in response to interferon gamma (IFNγ), thereby evading NK‐cell lysis. Blocking IFNγ signaling or treatment with dimethyl fumarate/simvastatin counteracts this immune escape and maintains NK‐cell ...
Lena C. M. Krause+6 more
wiley +1 more source
Editorial: Application of neuroscience in information systems and software engineering. [PDF]
Pryss R+5 more
europepmc +1 more source
The democratization of bioinformatics: A software engineering perspective. [PDF]
Lawlor B, Sleator RD.
europepmc +1 more source
Characteristics of mathematical modeling languages that facilitate model reuse in systems biology: a software engineering perspective. [PDF]
Schölzel C+3 more
europepmc +1 more source
Using laboratories to teach software engineering principles in the introductory computer science curriculum [PDF]
James Robergé, Candice Suriano
openalex +1 more source
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang+8 more
wiley +1 more source